Exabis Library
Welcome to the e-CCO Library!
P748: Pharmacokinetics, relative bioavailability, and dose proportionality of a tablet formulation of the sphingosine 1-phosphate-1 receptor modulator VTX002 (formerly OPL-002)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P748: Retrospective study on incidence rates of NAFLD and advanced liver fibrosis in Crohn's disease and ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P749 Epidemiological and clinical characterisation of inflammatory bowel disease (IBD) in Latin America and the Caribbean: The EPI-LATAM IBD study from the Pan American Crohn’s colitis organisation
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P749: A comparative analysis of low bioavailability steroids in inducing clinical response and remission in ulcerative colitis: Budesonide MMX as the safest option
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P749: Crohn's disease stricture response and resolution with adalimumab therapy demonstrated with intestinal ultrasound. The STRIDENT randomised trial.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P749: Early environmental and lifestyle factors are associated with developing inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P749: Impact of psycho-social variables on the activity of inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P750 Prevalence and characteristics of incidentally diagnosed inflammatory bowel disease during screening colonoscopy
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P750: Association between the use of antihypertensive agents and disease severity in patients with inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P750: Biosimilar Infliximab Switching is Not Associated with Adverse Outcomes: A Real-World Effectiveness Analyses in a National U.S. Cohort of U.S. Military Veterans with Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P750: Predictors of quick remission after cyclosporine A therapy in Paediatric ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P750: Prevalence and risk factors of cholelithiasis in patients with Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P751 Prevalence and risk factors of non-alcoholic fatty liver disease in inflammatory bowel diseases
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P751: Crohn's Disease Exclusion Diet: A single centre real-life experience.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P751: Perianal lesions in Crohn's disease: analysis of Epimad registry from 2007 to 2012
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P751: Time course of the incidence and magnitude of anti-drug antibodies to adalimumab and ABP 501 among patients on concomitant immunomodulatory therapy
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P751: Trends in incidence of inflammatory bowel disease in northwest Greece
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P752 A nationwide survey of chronic enteropathy associated with SLCO2A1 gene in Japan
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P752: Increased risk of hip fracture in patients with inflammatory bowel disease: a national registry-based nested case–control study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P752: Oral once daily budesonide granules rapidly induce clinical remission in Lymphocytic Colitis: A double-blind, double-dummy, multi-centre, randomised trial
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM